FIELD: medicine.
SUBSTANCE: blood serum of a patient suffering gestosis is quantitatively analysed for an alpha amylase level. If the alpha amylase level is >100 Units/l, severe gestosis is diagnosed.
EFFECT: use of the technique allows a well-timed and high preside diagnosis of severe gestosis.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR GESTOSIS DEGREE DETERMINATION | 2007 |
|
RU2342666C1 |
| METHOD OF DIAGNOSING SEVERE PREECLAMPSIA | 2015 |
|
RU2587781C1 |
| METHOD FOR PREDICTING EPH-GESTOSIS IN PREGNANT WOMEN SUFFERING FROM HYPERTENSION | 2004 |
|
RU2256180C1 |
| METHOD FOR PREECLAMPSIA SEVERITY ASSESSMENT BY RELATIVE CONTENT OF CD16+ MONOCYTES IN PERIPHERAL BLOOD OF PREGNANT WOMEN | 2019 |
|
RU2712228C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTION OF DEVELOPING SEVERE PREECLAMPSIA | 2012 |
|
RU2481578C1 |
| METHOD FOR DETERMINING SEVERITY OF GESTOSIS IN PREGNANT WOMEN | 2012 |
|
RU2521359C2 |
| METHOD FOR DIAGNOSING CHRONIC PLACENTAL INSUFFICIENCY CASES | 2006 |
|
RU2313795C1 |
| METHOD FOR PREDICTING TOXAEMIAS OF PREGNANCY | 2014 |
|
RU2553624C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
